Euroopa Liit - eesti - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. vt lõigud 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - diklofenak - geel - 10mg 1g 25g 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - diklofenak - toimeainet modifitseeritult vabastav tablett - 75mg 20tk; 75mg 100tk; 75mg 10tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - diklofenak - süstelahus - 75mg 2ml 2ml 3tk; 75mg 2ml 2ml 10tk; 75mg 2ml 2ml 5tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - diklofenak - rektaalsuposiit - 50mg 10tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - diklofenak - toimeainet modifitseeritult vabastav tablett - 150mg 100tk; 150mg 20tk; 150mg 10tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - diklofenak - toimeainet modifitseeritult vabastav tablett - 150mg 20tk; 150mg 50tk; 150mg 100tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - diklofenak - rektaalsuposiit - 100mg 10tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - diklofenak - gastroresistentne tablett - 50mg 20tk; 50mg 50tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - diklofenak - süstelahus - 25mg 1ml 3ml 50tk